19.09.2018
- At Chemoutsourcing conference 2017, Jean-Jacques (John) Mondoloni, Managing Partner at Wombat Capital, chaired and moderated a round table on the topic “How Is The M&A Rush Shaking...
31.08.2018
- Outsourcing is about the efficiencies of globalization, expense, people, and the challenge of drug discovery. Big Pharma has consolidated and faltered over the past 15 to 20 years...
02.10.2017
- Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Simon Edwards: It is somewhat...
28.09.2017
- Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Mark Rogers: Between 1993 and...
28.09.2017
- Daniel Mueller: The most obvious effect of consolidation in the pharmaceutical industry is a pronounced shift to those activities within the organization that provide the most...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Elliott Berger: With the ever-increasing share of...
28.09.2017
- Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. What do the outsourcing partners have to do in order to...
28.09.2017
- Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass...
